Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Remogliflozin Etabonate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Delhi High Court seeks response from govt, NPPA on Glenmark's plea
    Delhi High Court seeks response from govt, NPPA on Glenmark's plea

    09 Apr 2024

    // Indu Bhan ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-high-court-seeks-response-from-govt-nppa-on-glenmarks-plea/articleshow/109169586.cms

    Indu Bhan ECONOMIC TIMES
    09 Apr 2024
    Share Share
    Glenmark Pharma launches FDC drug for type 2 diabetes
    Glenmark Pharma launches FDC drug for type 2 diabetes

    26 Oct 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143498&sid=2

    PHARMABIZ
    26 Oct 2021
    Share Share
    Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
    Glenmark becomes the first company to launch Remogliflozin + Vildagliptin

    29 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/in/news-releases/glenmark-becomes-the-first-company-to-launch-remogliflozin-vildagliptin-fixed-dose-combination-at-an-affordable-price-for-adults-with-type-2-diabetes-in-india-821947177.html

    PRNEWSWIRE
    29 Dec 2020
    Share Share
    Natco launches cut-price copies of AstraZeneca's patented anti-diabetes drug
    Natco launches cut-price copies of AstraZeneca's patented anti-diabetes drug

    07 Apr 2020

    // Vikas Dandekar ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-launches-cut-price-copies-of-astrazenecas-patented-anti-diabetes-drug/articleshow/75022602.cms

    Vikas Dandekar ECONOMIC TIMES
    07 Apr 2020
    Share Share
    Mankind Pharma signs up with Glenmark Pharmaceuticalsto co-market diabetes drug
    Mankind Pharma signs up with Glenmark Pharmaceuticalsto co-market diabetes drug

    23 Dec 2019

    // ECONOMIC TIMES

    https://health.economictimes.indiatimes.com/news/pharma/mankind-pharma-signs-up-with-glenmark-pharmaceuticals-for-co-marketing-of-remogliflozin-etabonate-in-india/72936643

    ECONOMIC TIMES
    23 Dec 2019
    Share Share
    Glenmark launches Remogliflozin combo in India; GeneCentric buys Select Immuno
    Glenmark launches Remogliflozin combo in India; GeneCentric buys Select Immuno

    19 Aug 2019

    // ENDPTS

    https://endpts.com/glenmark-launches-remogliflozin-combo-in-india-genecentric-therapeutics-buys-select-immunogenomics/

    ENDPTS
    19 Aug 2019
    Share Share